Industrial conglomerate Emerson (NYSE:EMR) offers an interesting case-study for investors after reporting its second quarter numbers. Should investors overlook a small stumble from an otherwise reliable and well-run industrial company, or should investors flee at this first sign of trouble and move into hotter names?
How an investor answers this question probably goes straight to the heart of their philosophy as an investor. Patient investors who seek out well-run companies for long-term gains should probably think of adding more, while investors who embrace higher turnover may well find it is time to chase faster prey.
Some Turbulence in a Strong Q2
On the whole, Emerson had a solid second quarter report, but the results were a little shy of analyst expectations - and for better or worse, that does shape a lot of near-term stock performance.
Please click this link for the full article:
http://stocks.investopedia.
2 comments:
You make note of other bargins at the end of the article, what are they?
In industrials?
Siemens
3M (which I own)
UTX
maybe ITW (though that's pretty close to on-par with EMR).
and then there's a whole host of companies in other sectors (healthcare, financials, some tech) that look cheaper.
Post a Comment